Vol. 146, No. 23 — June 9, 2012

COMMISSIONS

CANADIAN INTERNATIONAL TRADE TRIBUNAL

DETERMINATION

Professional, administrative and management support services

Notice is hereby given that, after completing its inquiry, the Canadian International Trade Tribunal (the Tribunal) made a determination (File No. PR-2011-061) on May 28, 2012, with respect to a complaint filed by The Masha Krupp Translation Group Limited (MKTG), of Ottawa, Ontario, pursuant to subsection 30.11(1) of the Canadian International Trade Tribunal Act, R.S.C. 1985 (4th Supp.), c. 47, concerning a procurement (Solicitation No. 1000117933) by the Public Health Agency of Canada (PHAC). The solicitation was for the provision of translation services.

MKTG alleged that the PHAC improperly evaluated its proposal.

Having examined the evidence presented by the parties and considered the provisions of the Agreement on Internal Trade, the Tribunal determined that the complaint was not valid.

Further information may be obtained from the Secretary, Canadian International Trade Tribunal, Standard Life Centre, 15th Floor, 333 Laurier Avenue W, Ottawa, Ontario K1A 0G7, 613-993-3595 (telephone), 613-990-2439 (fax), secretary@citt-tcce.gc.ca (email).

Ottawa, May 29, 2012

GILLIAN BURNETT
Acting Secretary

[23-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

NOTICE TO INTERESTED PARTIES

The Commission posts on its Web site the decisions, notices of consultation and regulatory policies that it publishes, as well as information bulletins and orders. On April 1, 2011, the Canadian Radio-television and Telecommunications Commission Rules of Practice and Procedure came into force. As indicated in Part 1 of these Rules, some broadcasting applications are posted directly on the Commission’s Web site, www.crtc.gc.ca, under “Part 1 Applications.”

To be up to date on all ongoing proceedings, it is important to regularly consult “Today’s Releases” on the Commission’s Web site, which includes daily updates to notices of consultation that have been published and ongoing proceedings, as well as a link to Part 1 applications.

The following documents are abridged versions of the Commission’s original documents. The original documents contain a more detailed outline of the applications, including the locations and addresses where the complete files for the proceeding may be examined. These documents are posted on the Commission’s Web site and may also be examined at the Commission’s offices and public examination rooms. Furthermore, all documents relating to a proceeding, including the notices and applications, are posted on the Commission’s Web site under “Public Proceedings.”

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

PART 1 APPLICATIONS

The following applications were posted on the Commission’s Web site between May 25, 2012, and May 31, 2012:

Télévision MBS inc.
Various locations in Quebec; and Edmundston, New Brunswick
2012-0626-9
Temporary amendment to a condition of licence for CFTF-TV
Deadline for submission of interventions, comments and/or answers: June 26, 2012

Acadia Broadcasting Limited
Kenora, Ontario
2012-0636-8
Complaint against Golden West Broadcasting Ltd. related to the programming on their rebroadcasting transmitter
Deadline for submission of interventions, comments and/or answers: July 3, 2012

[23-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

NOTICE OF CONSULTATION

2012-311 May 28, 2012

Notice of application received

Winnipeg, Manitoba
Deadline for submission of interventions, comments and/or answers: July 3, 2012

The Commission has received the following application:

  1. CreComm Radio Inc. Winnipeg, Manitoba

     Application to renew the broadcasting licence for the campus instructional radio programming undertaking CKIC-FM Winnipeg, expiring August 31, 2012.

[23-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

DECISIONS

The complete texts of the decisions summarized below are available from the offices of the CRTC.

2012-314 May 30, 2012

Complaint regarding the broadcast of a police radio transmission by the Canadian Broadcasting Corporation (CBC) following the death of a police officer.

The Commission finds that the CBC’s broadcast of a police radio transmission on June 28, 2011, as part of the program “CBC News Toronto at 6” did not violate the Broadcasting Act, the CBC’s Journalistic Standards and Practices or the Canadian Association of Broadcasters’ Violence Code.

2012-316 May 31, 2012

V Interactions inc.
Saguenay, Quebec

Approved — Application to change the authorized contours of the transmitter CFRS-DT Saguenay.

[23-1-o]

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

Claimant

Product
Identifier (As shown on the MSDS)

Registry Number

MSDS Preparation Date (As shown on the MSDS)

Date of Decision

Lens Technology I, LLC, La Mirada, California

SUN-400-B polycarbonate Coating

7567

January 13, 2010

October 14, 2011

Gourley’s Auto Parts Ltd., Keswick Ridge, New Brunswick

180

7696

December 1, 2009

September 15, 2011

Champion Technologies Ltd., Calgary, Alberta

Assure® HI-203

7725

08/21/2009

August 22, 2011

Champion Technologies Ltd., Calgary, Alberta

Emulsotron® X-8185

7726

08/24/2009

August 22, 2011

Champion Technologies Ltd., Calgary, Alberta

Emulsotron® X-8127

7727

08/24/2009

August 22, 2011

Recochem Inc., Milton, Ontario

OAT LD ELC-N 5X SC

7734

05/11/2010

August 19, 2011

Clearwater International, Houston, Texas

SULFA CLEAR® 8640

7739

25-November-2009

September 20, 2011

3M Canada Company, London, Ontario

3M(TM) Heavy Drip-Chek(TM) Sealer, P.N. 08531

7751

2009/10/08

November 30, 2011

Clearwater International Ltd., Houston, Texas

ALPHA 2095

7761

04-February-2010

August 30, 2011

BYK USA Inc., Wallingford, Connecticut

BYK-W 966

7762

12/14/2009

August 19, 2011

Calfrac Well Services Ltd., Calgary, Alberta

DCP-FL3

7769

March 18, 2010

November 30, 2011

Hexion Specialty Chemicals Inc.,* Oshawa, Ontario
* formerly Hexion Specialty Chemicals Canada Inc.

StructurFast® OS-518SA

7789

13-May-2010

September 26, 2011

Recochem Inc., Milton, Ontario

OAT LD ELC-WB 10X SC

7832

03/03/2010

August 19, 2011

Recochem Inc., Milton, Ontario

Recochem OAT Coolant 10X SC Low Glycol

7833

17/02/2010

August 19, 2011

Rohm and Haas Canada LP, West Hill, Ontario

PARALOID(TM) K-416 Processing Aid

7840

03/24/2010

November 30, 2011

Stone Chemical Company, Naperville, Illinois

AN900L FUME SUPPRESSANT

7841

August 3, 2010

August 10, 2011

Weatherford International Ltd., Houston, Texas

ALPHA 3069

7846

08-April-2010

August 29, 2011

OSP Microcheck, Calgary, Alberta

ODP 1127 SILICA SCALE MANAGER

7848

April 23, 2010

September 8, 2011

Afton Chemical Corporation, Richmond, Virginia

FS Clean Flow

7857

10 November 2010

November 24, 2011

Afton Chemical Corporation, Richmond, Virginia

LUBAD 1309

7860

5/17/2010

November 16, 2011

Afton Chemical Corporation, Richmond, Virginia

LUBAD 1602

7862

2/18/2010

November 30, 2011

BASF Canada Inc., Mississauga, Ontario

Irganox mL 820

7868

2010/08/10

November 29, 2011

BASF Canada Inc., Mississauga, Ontario

Irganox mL 840

7869

2010/08/10

October 13, 2011

BASF Canada Inc., Mississauga, Ontario

IRGACOR® L 12

7871

2010/08/31

November 16, 2011

Afton Chemical Corporation, Richmond, Virginia

LUBAD 1697

7899

5/7/2010

November 30, 2011

Blendco Systems, LLC, Bristol, Pennsylvania

HPH Powder (SS)

7905

10/22/2010

October 28, 2011

Blendco Systems, LLC, Bristol, Pennsylvania

HA Powder

7907

10/22/2010

October 28, 2011

Brine-Add Fluid Ltd., Calgary, Alberta

ProMul

7920

July 22, 2010

October 31, 2011

Trican Well Service Ltd., Calgary, Alberta

SS-3

7941

November 18, 2010

September 9, 2011

Trican Well Service Ltd., Calgary, Alberta

PL-1

7942

05/03/2010

August 22, 2011

Rohm and Haas Canada LP, West Hill, Ontario

PARALOID(TM) EXL 2314

7943

09/02/2010

August 30, 2011

Nalco Canada Co., Burlington, Ontario

NALCO® EC3397A

7944

2010/08/19

November 4, 2011

Nalco Canada Co., Burlington, Ontario

NALCO® EC3292A

7945

2010/08/19

November 8, 2011

Hilti Inc., Tulsa, Oklahoma

Hilti Epoxy Grout (EG)

7946

12/16/2010

November 22, 2011

Trican Well Service Ltd., Calgary, Alberta

FC-2

7947

November 18, 2010

August 22, 2011

Hexion Specialty Chemicals Inc.,* Oshawa, Ontario
* formerly Hexion Specialty Chemicals Canada Inc.

FentakÔ MR0444

7951

01-SEP-2010

September 26, 2011

Champion Technologies, Calgary, Alberta

FlowPlusÔ VR-1100

7953

01/25/2011

November 29, 2011

Brine-Add Fluid Ltd., Calgary, Alberta

CES Secondary

7962

September 17, 2010

November 28, 2011

Afton Chemical Corp., Richmond, Virginia

SURE-FLO IV ULS

7964

27 September 2010

November 1, 2011

Nalco Canada Co., Burlington, Ontario

NALCO 9729 SCALE CONTROL

7969

2010/10/08

October 31, 2011

Nalco Canada Co., Burlington, Ontario

ACRYL-EX® EC3085A

7970

2010/10/05

August 22, 2011

Huntsman Corp., The Woodlands, Texas

RUBINATE® 1790

7971

July 18/2011

August 29, 2011

Northspec Chemicals Corporation, Toronto, Ontario

ETERCURE 6146-100

7972

June 22, 2011

November 29, 2011

Cookson Electronics,
South Plainfield, New Jersey

WS-362-25 HF FLUX

7981

12/7/2010

September 15, 2011

Cookson Electronics,
South Plainfield, New Jersey

615 TYPE RMA FLUX

7983

12/7/2010

October 4, 2011

Cookson Electronics,
South Plainfield, New Jersey

615-15 RMA FLUX

7984

12/7/2010

October 4, 2011

Cookson Electronics,
South Plainfield, New Jersey

615-25 ROSIN FLUX RMA

7985

12/7/2010

October 4, 2011

Cookson Electronics,
South Plainfield, New Jersey

ALPHA® RMA-390DH4-LV Paste Flux

7988

1/10/2011

October 14, 2011

Cookson Electronics,
South Plainfield, New Jersey

EF-8000 NO CLEAN FLUX

7993

2/15/2011

November 17, 2011

Cookson Electronics,
South Plainfield, New Jersey

FNR 200 FLUX

7995

2/15/2011

October 28, 2011

Cookson Electronics,
South Plainfield, New Jersey

NR330 VOC FREE NO CLEAN

7997

2/16/2011

September 15, 2011

Cookson Electronics,
South Plainfield, New Jersey

ROSIN FLUX 800

7999

2/18/2011

October 28, 2011

Cookson Electronics,
South Plainfield, New Jersey

SC-30 STENCIL CLEANER

8000

2/16/2011

October 28, 2011

Cookson Electronics,
South Plainfield, New Jersey

ALPHA® SC-7525 Alpha Cleaner

8006

6/10/2011

November 30, 2011

Baker Petrolite Corp., Sugar Land, Texas

HI-M-PACTÔ 6052 LDHI

8028

10/19/2010

August 29, 2011

Baker Petrolite Corp., Sugar Land, Texas

SCW4477 SCALE INHIBITOR

8029

10/19/2010

August 29, 2011

Baker Petrolite Corp., Sugar Land, Texas

SRW4437 SILICATE SCALE DISSOLVER

8030

11/28/2011

November 30, 2011

3M Canada Company, London, Ontario

3M(TM) Scotch-Weld(TM) Structural Plastic Adhesive DP8005, Part B

8033

January 26, 2011

November 30, 2011

3M Canada Company, London, Ontario

3M(TM) Scotch-Weld(TM) Structural Plastic Adhesive 8005, Black, Part B

8034

January 26, 2011

November 30, 2011

Construction DJL Inc., Carignan,* Quebec
* formerly from Boucherville, Quebec

Emulrupt C

8035

le 21 octobre 2010

August 16, 2011

Nalco Canada Co., Burlington, Ontario

CLEAN N COR® EC1539A

8037

2010/10/26

November 3, 2011

3M Canada Company, London, Ontario

04247 DURAMIX (TM) Super Fast Plastic Repair Adhesive (Part A)

8038

2010/11/04

November 30, 2011

Nalco Canada Co., Burlington, Ontario

Clean n Cor® EC1508A

8042

2010/08/10

September 6, 2011

Baker Petrolite Corp., Sugar Land, Texas

SULFIX™ 9260 H2S SCAVENGER

8044

11/16/2010

August 29, 2011

Momentive Performance Materials, Markham, Ontario

Silquest® A-Link 597(TM) silane

8046

03/01/2011

November 2, 2011

Momentive Performance Materials, Markham, Ontario

Silquest® A-1230 silane

8047

03/01/2011

August 4, 2011

DIACON Technologies Ltd.,* Richmond, Virginia
* formerly Diacon Technologies Ltd.

CEDARBRITE

8048

November 22, 2010

November 30, 2011

Chevron Oronite Company LLC, Bellaire, Texas

ST 3202

8049

November 23, 2010

November 17, 2011

Afton Chemical Corp., Richmond, Virginia

HiTEC 5777A Performance Additive

8050

11/23/2010

November 30, 2011

Afton Chemical Corp., Richmond, Virginia

HiTEC 6589C Fuel Additive

8051

11/30/2010

November 30, 2011

Akzo Nobel Surface Chemistry LLC, Chicago, Illinois

ETHYLANÔ 1005 SA

8059

11/30/2010

August 8, 2011

Rohm and Haas Canada LP, West Hill, Ontario

MONOMER QM-1458

8067

01/13/2011

November 28, 2011

Rohm and Haas Canada LP, West Hill, Ontario

MONOMER QM-516

8068

01/13/2011

November 28, 2011

Rohm and Haas Canada LP, West Hill, Ontario

MONOMER QM-833M

8069

01/13/2011

November 28, 2011

Bayer Inc., Toronto, Ontario

BAYHYDUR VP LS 2310

8076

Jan 04/11

September 26, 2011

3M Canada Company, London, Ontario

3M(TM) Scotch-Weld(TM) Structural Plastic Adhesive DP8005, Black, Part B

8077

2011/03/21

November 30, 2011

Momentive Performance Materials, Markham, Ontario

Niax® Silicone L-636S

8078

03/17/2011

October 14, 2011

Chevron Oronite Company LLC, Bellaire, Texas

OGA 72040

8086

January 31, 2011

October 26, 2011

Chevron Oronite Company LLC, Bellaire, Texas

OGA 72043

8087

January 31, 2011

October 26, 2011

Chevron Oronite Company LLC, Bellaire, Texas

OLOA 1255

8095

March 17, 2011

October 26, 2011

Chevron Oronite Company LLC, Bellaire, Texas

LUBAD 651

8096

March 18, 2011

October 26, 2011

Baker Petrolite Corp., Sugar Land, Texas

RE10274RBW WATER CLARIFIER

8099

02/10/2011

November 30, 2011

Momentive Specialty Chemicals Inc., Oshawa, Ontario

FentekÔ UR0269

8107

21-FEB-2011

October 5, 2011

Afton Chemical Corp., Richmond, Virginia

HiTEC 6431 Fuel Additive

8109

17 February 2011

November 28, 2011

BASF Canada Inc., Mississauga, Ontario

PureOptionsÔ VUL High Hide Violet

8120

2011/03/11

November 29, 2011

Matrix Drilling Fluids Ltd., Calgary, Alberta

MATRIX BITU-BINDER

8125

March 15, 2011

November 30, 2011

Notes:

  1. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 28, 2009, listed the subject of the claim bearing Registry Number 7567 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentrations of nine ingredients.
  2. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on November 21, 2009, listed the subject of the claim bearing Registry Number 7696 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.
  3. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on November 21, 2009, listed the product identifier bearing Registry Number 7725 to be Assure HI-203. The product identifier on which the screening officer issued the decision is Assure® HI-203.
  4. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on November 21, 2009, listed the product identifier and subject of the claim bearing Registry Number 7726 to be the Emulsotron X-8185 and the chemical identity and concentration of one ingredient. The product identifier and subject of the claim on which the screening officer issued the decision is Emulsotron® X-8185 and the chemical identity of three ingredients.
  5. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on November 21, 2009, listed the product identifier bearing Registry Number 7727 to be Emulsotron X-8127. The product identifier on which the screening officer issued the decision is Emulsotron® X-8127.
  6. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on November 21, 2009, listed the subject of the claim bearing Registry Number 7734 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of four ingredients and the name of a toxicological study which identifies a controlled ingredient.
  7. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on November 21, 2009, listed the subject of the claim bearing Registry Number 7739 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  8. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 13, 2010, listed the subject of the claim bearing Registry Number 7769 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.
  9. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7840 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of three ingredients.
  10. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, for the claim bearing Registry Number 7841 listed the product identifier as “STONE AN900L FUME SUPPRESSANT” and the subject of the claim to be the chemical identity of two ingredients. The product identifier and the subject of the claim on which the screening officer issued the decision is “AN900L FUME SUPPRESSANT” and the chemical identity of one ingredient.
  11. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7846 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  12. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7857 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  13. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7862 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  14. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7868 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  15. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7869 to be the chemical identity of six ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  16. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the product identifier for the claim bearing Registry Number 7871 to be “Irgacor L 12”. The product identifier for the claim on which the screening officer issued the decision is “IRGACOR® L 12”.
  17. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 10, 2010, listed the subject of the claim bearing Registry Number 7907 to be the chemical identity of four ingredients and the concentration of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients and concentration of four ingredients.
  18. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, for the claim bearing Registry Number 7943 listed the product identifier as “Paraloid(TM) EXL 2314” and the subject of the claim to be the chemical identity of one ingredient. The product identifier and the subject of the claim on which the screening officer issued the decision is “PARALOID(TM) EXL 2314” and the chemical identity of three ingredients.
  19. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7946 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  20. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7953 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient and concentration of two ingredients.
  21. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the product identifier for the claim bearing Registry Number 7962 to be “CES SECONDARY”. The product identifier for the claim on which the screening officer issued the decision is “CES Secondary”.
  22. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7981 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  23. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7983 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  24. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7984 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  25. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7985 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  26. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7988 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  27. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7993 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  28. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7995 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  29. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 7999 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  30. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 8000 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  31. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 8029 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  32. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on October 30, 2010, listed the subject of the claim bearing Registry Number 8030 as the information that could be used to identify a supplier of a controlled product. The subject of the claim on which the screening officer issued the decision is the chemical name, common name, generic name, trade name or brand name of a controlled product and the information that could be used to identify a supplier of a controlled product.
  33. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claims bearing Registry Numbers 8033 and 8034 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  34. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8035 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.
  35. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8050 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  36. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8051 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  37. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8077 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  38. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8109 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  39. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8120 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDSs, in respect of the claims bearing Registry Numbers 7762, 7840, 7943, 7969, 8030, 8038, 8048, 8095, 8096 and 8107, which were filed complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

In all cases where the material safety data sheet or the label was determined not to be in compliance with the relevant legislation, the screening officer offered the claimant the possibility of entering into an undertaking whereby the claimant would voluntarily make the changes necessary to bring the MSDS or the label into compliance. Pursuant to subsection 16.1(1) of the Hazardous Materials Information Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

In the case of the following claims, the claimant supplied the screening officer with a signed undertaking accompanied by the MSDS or label amended as necessary within the time frame specified. The screening officer was satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified therein.

CLAIMS WHERE THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of any information that has been disclosed on the relevant material safety data sheet or label in compliance with an undertaking.

Registry Number 7567

Date of notice confirming acceptance: December 12, 2011

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of one more confidential business ingredient which can be characterized by the generic chemical identity “aliphatic polyol salt” and disclose that the real chemical identity and concentration are included in the claim for exemption.
  2. Disclose an LD50 (dermal, rabbit) for “acrylated monomer A”; an LD50 (oral, rat) for “acrylated monomer B1”; an LD50 (dermal, rabbit) for “acrylated monomer B1”; an LD50 (oral, rat) for “acrylated monomer B2” and an LD50 (dermal, rabbit) for “acrylated monomer B2”, in an acceptable manner.
  3. Disclose an LD50 (oral, rat) and an LD50 (dermal, rabbit) for “epoxide resin 1”, in an acceptable manner.
  4. Disclose an LD50 (oral, rat) for “aliphatic polyol salt”, in an acceptable manner.
  5. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes.
  6. In relation to the first aid information shown on the MSDS for ingestion, remove the advice to give 250–300 mL (8–10 oz) of water.
  7. Disclose that oral exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.
  8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacteria and mammalian cells, in vitro.
  9. Disclose that “acrylated monomer B1” and “acrylated monomer B2” in the controlled product have been shown to cause eye corrosion in laboratory animals.
  10. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 7696

Date of notice confirming acceptance: November 10, 2011

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that inhalation exposure to an ingredient in the controlled product has been shown to cause reproductive toxicity in laboratory animals.
  2. Disclose the generic chemical ingredients “silicone #1”, “silicone #2”, and “petroleum distillate #3” together with their accepted WHMIS concentrations.
  3. Add oxides of carbon and nitrogen to the list of hazardous combustion products.
  4. Disclose an LC50 (aerosol, rat, 4 hours) value for the confidential hazardous ingredient “petroleum distillates #2”, in an acceptable manner.
  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7725

Date of notice confirming acceptance: November 10, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute inhalation of an ingredient in the controlled product has caused central nervous system (CNS) depression in laboratory animals.
  2. Disclose that acute ingestion of “methanol” in the controlled product has resulted in various adverse central nervous system (CNS) effects, including gastrointestinal symptoms, respiratory impairment, brain damage and death in humans.
  3. Disclose that acute dermal exposure to an ingredient in the controlled product has caused central nervous system (CNS) depression in laboratory animals.
  4. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed with water for at least 15 minutes or until the chemical is removed.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  6. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
  7. Disclose that the product is incompatible with aluminum and magnesium.
  8. Disclose a lower LD50 (oral, rat) value of 3 523 mg/kg for the ingredient “xylene”.
  9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause damage to hearing organs in laboratory animals.
  10. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
  11. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity and developmental toxicity in laboratory animal fetuses, in the absence of maternal toxicity.
  12. Disclose that “xylene” interacts synergistically with “N-hexane” to enhance hearing loss in laboratory animals.

Registry Number 7726

Date of notice confirming acceptance: November 17, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute inhalation of an ingredient in the controlled product has caused central nervous system (CNS) depression in laboratory animals.
  2. Disclose that acute ingestion of “methanol” in the controlled product has resulted in various adverse central nervous system (CNS) effects, including gastrointestinal symptoms, respiratory impairment, brain damage and death in humans.
  3. Disclose that acute dermal exposure to an ingredient in the controlled product has caused central nervous system (CNS) depression in laboratory animals.
  4. Disclose the generic chemical ingredients “oxyalkylated amine” and “oxyalylated polymerized polyol” and the accepted WHMIS concentrations.
  5. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed with water for at least 30 minutes.
  6. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  7. Add oxides of nitrogen and hydrogen chloride gas to the list of hazardous combustion products.
  8. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
  9. Disclose an LC50 (aerosol, rat, 4 hours) value for the confidential hazardous ingredient “organic acid”.
  10. Disclose an LC50 (vapour, rat, 8 hours) value of 19 000 ppm for “isopropyl alcohol”.
  11. Disclose that chronic oral exposure to an ingredient in the product may cause damage to the kidneys in laboratory animals.
  12. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity and developmental toxicity in laboratory animal fetuses, in the absence of maternal toxicity.
  13. Disclose that “xylene” interacts synergistically with “N-hexane” to enhance hearing loss in laboratory animals.

Registry Number 7727

Date of notice confirming acceptance: November 14, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute inhalation of an ingredient in the controlled product has caused central nervous system (CNS) depression in laboratory animals.
  2. Disclose that acute ingestion of “methanol” in the controlled product has resulted in various adverse central nervous system (CNS) effects, including gastrointestinal symptoms, respiratory impairment, brain damage and death.
  3. Disclose that acute dermal exposure to an ingredient in the controlled product has caused central nervous system (CNS) depression in laboratory animals.
  4. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed with water for at least 15 minutes or until the chemical is removed.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  6. Add oxides of sulfur to the list of hazardous combustion products.
  7. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
  8. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause damage to hearing organs in laboratory animals.
  9. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
  10. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity and developmental toxicity in laboratory animal fetus, in the absence of maternal toxicity.
  11. Disclose that “xylene” interacts synergistically with “N-Hexane” to enhance hearing loss in laboratory animals.

Registry Number 7739

Date of notice confirming acceptance: October 27, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “amine derivative B” in the controlled product has been shown to cause eye corrosion in animals.
  2. Disclose that the confidential hazardous ingredients “amine derivative B” and “amine derivative F” in the controlled product have been shown to cause skin corrosion in animals.
  3. Disclose the chemical identity and concentration of the ingredients “amine derivative C”, “amine derivative D”, “amine derivative E” and “amine derivative F” in an acceptable manner.
  4. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with lukewarm, gently flowing water for at least 30 minutes.
  5. In relation to the first aid information shown on the MSDS for ingestion, add a statement that if vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
  6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.
  7. In relation to the first aid information for ingestion shown on the MSDS, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  8. Disclose an ACGIH TLV–TWA Exposure Limit of 3 ppm and an ACGIH TLV–STEL value of 6 ppm for the confidential hazardous ingredient “amine derivative F”.
  9. Add oxides of carbon and nitrogen to the list of hazardous decomposition products.
  10. Disclose an LD50 (oral, female rat) value of 763 mg/kg for the ingredient “triazine”, an LD50 (oral, female rat) value of 238 mg/kg for the confidential hazardous ingredient “amine derivative B”, an LD50 (oral, female rat) value of 9 690 mg/kg for the ingredient “methanol” and an LD50 (oral, female rat) value of 1 720 mg/kg for the confidential hazardous ingredient “amine derivative F”.
  11. Disclose an LD50 (dermal, rabbit) value of 395 mg/kg for the confidential hazardous ingredient “amine derivative B” and an LD50 (dermal, rabbit) value of 1 018 mg/kg for the confidential hazardous ingredient “amine derivative F”.
  12. Disclose that the ingredient “triazine” has been shown to cause mutagenic effects in bacterial cells, in vitro.
  13. Disclose that ingestion and inhalation of “methanol” has been shown to cause teratogenic effects in the absence of maternal toxicity and that ingestion of the confidential hazardous ingredient “amine derivative F” has been shown to cause teratogenic effects in the presence and absence of maternal toxicity.
  14. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1B and E.
  15. If the WHMIS classifications or pictograms are shown on the MSDS, display the additional D1 pictogram (skull and crossbones) and E pictogram (spill on hand).

Registry Number 7751

Date of notice confirming acceptance: December 21, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in the absence of maternal toxicity.
  2. Disclose the CAS registry number and concentration for “xylene”.
  3. Disclose an ACGIH TLV–TWA Exposure Limit of 100 ppm and an ACGIH TLV–STEL Exposure Limit of 150 ppm for the ingredient “xylene”.
  4. Disclose an ACGIH TLV–TWA Exposure Limit of 20 ppm for the ingredient “ethylbenzene”.

Registry Number 7761

Date of notice confirming acceptance: October 17, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Add oxides of nitrogen and hydrogen chloride gas to the list of hazardous decomposition products.
  3. Disclose that the product is incompatible with aluminum and magnesium.
  4. Disclose an LD50 (oral, rat) value of 9 690 mg/kg for the ingredient “methanol”.
  5. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause acidosis, permanent eye effect and brain damage in humans.
  6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals in the absence of maternal toxicity.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 7789

Date of notice confirming acceptance: October 27, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes.

Registry Number 7841

Date of notice confirming acceptance: August 31, 2011

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause teratogenicity effects in laboratory animals at maternally non-toxic levels.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that medical attention should be obtained immediately.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7846

Date of notice confirming acceptance: October 17, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute inhalation of an ingredient in the controlled product has caused central nervous system (CNS) effects in humans.
  2. Disclose that acute ingestion of an ingredient in the controlled product has caused eye effects, adverse central nervous system (CNS) effects, prolonged coma, respiratory failure, and death in humans.
  3. Disclose the presence of “3-(cocoamidopropyl) benzyldimethylamimonium chloride” in the controlled product, together with its CAS registry number and percent concentration.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  5. Disclose oxides of carbon, nitrogen, sulfur, and hydrogen chlorine to the list of hazardous combustion products.
  6. Disclose that an ingredient in the controlled product is incompatible with aluminum and magnesium.
  7. Disclose an LD50 (oral, rat) value of 9.7 g/kg for the ingredient “methanol” in the controlled product.
  8. Disclose that an ingredient in the controlled product has caused fetotoxic effects in laboratory animals, in the absence of maternal toxicity.
  9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 7848

Date of notice confirming acceptance: October 25, 2011

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 273 mg/kg for the ingredient “potassium hydroxide”.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with lukewarm, gently flowing water for at least 60 minutes while holding the eyelids open. Indicate that immediate medical attention should be obtained.
  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, footwear and leather goods should be removed under running water, the skin should be flushed with lukewarm, gently flowing water for at least 60 minutes, and medical advice should be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for ingestion, add a statement that if vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration and obtain medical advice immediately.
  5. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that medical advice should be obtained immediately.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 7857

Date of notice confirming acceptance: December 16, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity and the concentrations of two additional confidential hazardous ingredients, “poly(oxyalkylene)alkaryl ether” and “blue dye”, in the controlled product, in an acceptable manner.
  2. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 7860

Date of notice confirming acceptance: December 19, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity and the concentration of the confidential hazardous ingredient “polyofin amide alkeneamine” in the controlled product, in an acceptable manner.
  2. Disclose the concentration range for the confidential hazardous ingredient “alkoxylated long-chain alkanol borate”, in an acceptable manner.
  3. Disclose all confidential hazardous ingredients under the generic chemical identity “alkyl phosphate” in an acceptable manner.
  4. Disclose an LD50 (oral, rat) value of 4.94 mL/kg and an LD50 (dermal, rabbit) value of 1.25 mL/kg for the confidential hazardous ingredient “alkyl phosphate I”.
  5. Disclose an LD50 (oral, rat) value of 2.71 g/kg for the confidential hazardous ingredient “alkyl phosphate II”.
  6. Disclose an LD50 (oral, rat) value of 3.2 g/kg and an LD50 (dermal, rabbit) value of 2.0 mL/kg for the confidential hazardous ingredient “alkyl phosphonate”.
  7. Disclose an LD50 (oral and dermal) and species applicable for the confidential hazardous ingredient “long-chain alkyl amine”.
  8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 7862

Date of notice confirming acceptance: December 19, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity and the concentration of an additional ingredient “long-chain alkenyl amide”, in an acceptable WHMIS format.
  2. Disclose the generic chemical identity and the concentration of two additional ingredients “polyolefin amide alkeneamine” and “alkyl amine”, in an acceptable WHMIS format.
  3. Disclose an LD50 (oral, rat) value of 11.2 mL/kg for ingredient #1 “oleic acid, triethylenetetramine, dodecenylsuccinic anhydride reaction product”.

Registry Number 7868

Date of notice confirming acceptance: February 14, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the ingredient “alkylated diphenylamines” along with its WHMIS-acceptable concentration.

Registry Number 7871

Date of notice confirming acceptance: January 30, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 7899

Date of notice confirming acceptance: December 15, 2011

The claimant had been advised to amend certain aspects of the format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity and concentration of “organophosphate” in an acceptable WHMIS manner.
  2. Disclose an LD50 (oral, rat) value of 4.94 mL/kg and an LD50 (dermal, rabbit) value of 1.25 mL/kg for the confidential hazardous ingredient “alkyl phosphate I”.
  3. Disclose an LD50 (oral, rat) value of 2.71 g/kg for the confidential hazardous ingredient “alkyl phosphate”.
  4. Disclose an LD50 (oral, rat) value of 612 mg/kg, an LD50 (dermal, rabbit) value of 251 mg/kg and an LC50 (vapour, rat, 4 hours) value of 157 ppm for the confidential hazardous ingredient “long-chain alkyl amine”.
  5. Disclose that the controlled product is a skin sensitizer.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 7905

Date of notice confirming acceptance: November 30, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the kidneys as target organs.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be rinsed continuously with water for at least 60 minutes.
  3. Disclose that ingredients in the controlled product are incompatible with oxidizers, acids, ammonia, and chlorinated solvents.

Registry Number 7907

Date of notice confirming acceptance: November 30, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of exposure.
  2. Disclose the kidneys as target organs.
  3. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be rinsed continuously with water for at least 60 minutes.
  4. Disclose that ingredients in the controlled product are incompatible with oxidizers, acids and ammonia.
  5. Disclose that the confidential hazardous ingredient “inorganic alkaline mineral salt” has been shown to cause reproductive effects in laboratory animals.
  6. Disclose that ingestion of the confidential hazardous ingredient “inorganic alkaline mineral salt” has been shown to cause fetal malformations in laboratory animals, in the absence of maternal toxicity.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7920

Date of notice confirming acceptance: December 8, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, “tall oil fatty acid”, in the controlled product together with its CAS registry number and percent concentration.
  2. Disclose that an ingredient, “tall oil fatty acid”, in the controlled product is a skin sensitizer.
  3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 7941

Date of notice confirming acceptance: September 28, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects, hypotension and damage to the liver and kidneys in laboratory animals.
  2. In relation to the first aid information already disclosed on the MSDS for skin contact, add a statement to the effect that skin should be flushed continuously with water for 20 minutes.
  3. In relation to the first aid information for ingestion shown on the MSDS, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. Disclose an LD50 (dermal, rabbit) value of 8.0 mL/kg for “isopropanol”.
  5. Disclose that exposure to an ingredient in the controlled product has been shown to cause fetotoxic/teratogenic effects in the presence of maternal toxicity in laboratory animals.
  6. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacterial cells, in vitro.

Registry Number 7942

Date of notice confirming acceptance: September 22, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 7944

Date of notice confirming acceptance: November 21, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 7945

Date of notice confirming acceptance: December 6, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an acceptable LD50 (oral, rat) value for the confidential hazardous ingredient “substituted aromatic amine B”.

Registry Number 7946

Date of notice confirming acceptance: January 30, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

Part A — Resin
1. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian and bacterial cells, in vitro.
Part B — Hardener
2. Disclose the chemical identity for two additional ingredients, “alkylamine aldehyde reaction product” and “ethane diamine”, in the controlled product, and either their actual concentration or an acceptable range value.
3. Disclose an LD50 (dermal, rabbit) value of 0.56 mL/kg for “aliphatic amines” and 630 mg/kg for “phenol”.
4. Add skin absorption as an additional route of exposure.
5. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause liver, kidney and immune system damage.
6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lung, heart, liver and kidney damage.
7. Disclose that an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.
8. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in mammalian and bacterial cells, in vitro.
9. In relation to the first aid information shown on the MSDS for eye contact, add a statement to the effect that the eyes should be rinsed continuously with lukewarm, gently flowing water for at least 30 minutes while holding the eyelids open. Indicate that immediate medical attention should be obtained immediately.
10. In relation to the first aid information shown on the MSDS for skin contact, add a statement to the effect that dilution of “phenol” with water may enhance skin absorption. Avoid direct contact and wear chemical protective clothing. Remove contaminated clothing, shoes and leather goods immediately. Immediately and repeatedly wipe the affected area with 50% water solution of PEG 300 or PEG 400 (polyethylene glycol) or if not available, quickly blot or brush away excess chemical. Flush affected area with lukewarm, flowing water for at least 30 minutes. Immediately transport victim to emergency care facility. Double bag, seal, label and leave contaminated clothing, shoes and leather goods at the scene for safe disposal.
11. In relation to the first aid information shown on the MSDS for ingestion, add a statement that if vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
12. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.
13. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Part C — Aggregate Sand
14. Disclose an ACGIH TLV–TWA Exposure Limit of 0.025 mg/m3 and an A2 notation for the ingredient “silicon dioxide (quartz sand)”.
15. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 for the ingredient “aggregate blend”.
16. Disclose that acute inhalation of an ingredient in the controlled product has been shown to cause lung effects.
17. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause kidney and immunological autoimmune effects.
18. In relation to the first aid information shown on the MSDS for eye contact, add a statement to the effect that the eyes should be rinsed continuously with lukewarm, gently flowing water for at least 60 minutes while holding the eyelids open. Indicate that immediate medical attention should be obtained.
19. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that under running water, contaminated clothing, shoes and leather goods should be removed as soon as possible, continuously flush contaminated eyes with lukewarm, gently flowing water for at least 60 minutes and that medical attention be obtained immediately.
20. In relation to the first aid information shown on the MSDS for ingestion, add a statement that if vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
21. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

Registry Number 7947

Date of notice confirming acceptance: September 22, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
  2. Disclose that ingestion of an ingredient in the controlled product has been shown to cause fetotoxic/teratogenic effects in laboratory animals in the absence of maternal toxicity.

Registry Number 7951

Date of notice confirming acceptance: October 27, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, add a statement to the effect that skin should be flushed continuously with water for 20 minutes.
  2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should administer cardiopulmonary resuscitation (CPR) immediately if the heart has stopped.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 7953

The claimant has been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 20 minutes.
  2. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

Registry Number 7962

Date of notice confirming acceptance: December 28, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of ingredients “diethylene glycol mono butyl ether” (CAS Registry Number 112-34-5), “triethylene glycol butyl ether” (CAS Registry Number 143-22-6) and “tetraethylene glycol mono butyl ether” (CAS Registry Number 1559-34-8).
  2. Disclose the presence of the additional hazardous ingredients, “diethanolamine” (CAS Registry Number 111-42-2) and “tall oil fatty acid” (CAS Registry Number 61790-12-2) in the controlled product, together with their percent concentration.
  3. Disclose an LC50 (aerosol, rat, 4 hours) value of 1.72 mg/L for the ingredient “distillates (petroleum), hydrotreated light” and a lower LD50 (dermal, rabbit) value of 2 764 mg/kg for the ingredient “diethylene glycol mono butyl ether”.
  4. Disclose that the ingredient “diethiamolamine” has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).
  5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
  6. Disclose that the ingredient “tall oil fatty acid” in the controlled product is a skin sensitizer in laboratory animals.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7970

Date of notice confirming acceptance: October 13, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes.

Registry Number 7971

Date of notice confirming acceptance: September 28, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

Registry Number 7972

Date of notice confirming acceptance: December 29, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 7981

Date of notice confirming acceptance: October 14, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  2. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “isopropyl alcohol”.
  3. Disclose an LD50 (oral, rat) value and an LC50 (aerosol, rat, 4 hours) value for the confidential hazardous ingredient “polyalkylene glycol”, in an acceptable manner.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A and D2B.

Registry Number 7983

Date of notice confirming acceptance: November 15, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “amine” has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).
  2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  3. Disclose the generic chemical ingredient “amine” and its concentration in an acceptable WHMIS format.
  4. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 (IFV) for the confidential hazardous ingredient “amine”.
  5. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “isopropyl alcohol”.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7984

Date of notice confirming acceptance: November 15, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  2. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “isopropyl alcohol”.

Registry Number 7985

Date of notice confirming acceptance: November 15, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “amine” has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).
  2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  3. Disclose the generic chemical ingredient “amine” and its concentration in an acceptable WHMIS format.
  4. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 (IFV) for the confidential hazardous ingredient “amine”.
  5. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “isopropyl alcohol”.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7993

Date of notice confirming acceptance: February 16, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  2. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “propan-2-ol”.

Registry Number 7995

Date of notice confirming acceptance: February 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  2. Disclose that an ingredient in the controlled product has been shown to cause reproductive effects in laboratory animals.
  3. Disclose an ACGIH TLV–TWA Exposure Limit of 2 000 mg/m3 for the confidential hazardous ingredient “petroleum solvent naphtha”.
  4. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “propan-2-ol”.
  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 7997

Date of notice confirming acceptance: October 14, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 7999

Date of notice confirming acceptance: February 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  2. Disclose a lower LD50 (dermal, rabbit) value of 6 290 mg/kg for the ingredient “propan-2-ol”.

Registry Number 8000

Date of notice confirming acceptance: February 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause reproductive effects in laboratory animals.
  2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 8006

Date of notice confirming acceptance: February 17, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and developmental effects in the presence of maternal toxicity.
  2. Disclose an AIHA WEEL–TWA Exposure Limit of 3 ppm for the confidential hazardous ingredient previously referred to as “surfactant”.
  3. Disclose either a product LD50 (oral, rat) value of 5.75 g/kg or an LD50 (oral, rat) value of 4 400 mg/kg for the confidential hazardous ingredient previously referred to as “surfactant” and an LD50 (oral, rat) value of 4.7 g/kg for “propan-2-ol”.

Registry Number 8028

Date of notice confirming acceptance: October 13, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Add ingestion as a route of exposure.
  2. Disclose that ingestion overexposure of an ingredient in the controlled product has been shown to cause adverse central nervous system (CNS) effects in humans.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8029

Date of notice confirming acceptance: October 13, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.
  2. Add ingestion as a route of exposure.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8033

Date of notice confirming acceptance: January 3, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the concentration range for the confidential hazardous ingredient “methacrylate” in an acceptable manner.
  2. Disclose that the ingredient “2-ethylhexyl methacrylate” has caused skin sensitization in animals.

Registry Number 8034

Date of notice confirming acceptance: January 3, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the concentration range for the confidential hazardous ingredient “tetrahydrofurfuryl methacrylate” in an acceptable manner.

Registry Number 8035

Date of notice confirming acceptance: August 24, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH Exposure Limit of 2 mg/m3 for the ingredient “inorganic base”.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that medical attention should be obtained immediately.

Registry Number 8037

Date of notice confirming acceptance: December 6, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add ingestion as a route of exposure.
  2. Disclose the presence of an additional confidential hazardous ingredient in the controlled product under the generic chemical identity “fatty acid-amine condensate”, disclose its concentration in an acceptable manner and disclose that the real chemical identity is included in the claim for exemption.
  3. Disclose an LD50 (dermal, rabbit) value of 6.29 g/kg for the ingredient “isopropanol”.
  4. Disclose an LD50 (oral, rat) and an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “oxyalkylated alcohol” in an acceptable manner.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  6. Add hydrogen chloride gas and oxides of sulfur to the list of hazardous combustion products.

Registry Number 8042

Date of notice confirming acceptance: October 7, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Add ingestion as a route of exposure.
  2. Disclose a lower LD50 (dermal, rabbit) value of 8.0 mL/kg for the ingredient “isopropanol”.
  3. Add hydrogen chloride gas to the list of hazardous combustion products.

Registry Number 8044

Date of notice confirming acceptance: October 13, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add ingestion as a route of exposure.
  2. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes.

Registry Number 8046

Date of notice confirming acceptance: December 5, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of the ingredient “organoalkoxysilane heavies” in the controlled product, together with its percent concentration.
  2. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm, an ACGIH TLV–STEL Exposure Limit of 250 ppm and a skin notation (SKIN) for the hazardous ingredient “methanol”.
  3. Disclose that the claimant submitted an LD50 (oral, female rat) value of 1.46 mL/kg for the controlled product.
  4. Disclose that an ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals in the absence of maternal toxicity.

Registry Number 8047

Date of notice confirming acceptance: August 18, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to “drink plenty of water”.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to “induce vomiting if person is conscious”.
  4. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm, an ACGIH TLV–STEL Exposure Limit of 250 ppm and a skin notation (SKIN) for the ingredient “methanol”.
  5. Disclose an LD50 (oral, rat) value of >2 000 mg/kg and (dermal, rabbit) value of >2 000 mg/kg for the controlled product.

Registry Number 8049

Date of notice confirming acceptance: December 7, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) and cardiopulmonary effects, kidney damage, neurological impairment and death in humans.
  2. Disclose the additional ingredient “benzenesulfonic acid, methylmono-C20-24 branched alkyl derives, calcium salts” (CAS Registry Number 722503-68-6) in the controlled product, together with a concentration of 1.8%.
  3. Disclose an LD50 (oral, rat) value of 4 g/kg and an LD50 (dermal, rabbit) value of 9.53 mL/kg for the ingredient “ethylene glycol”.
  4. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver and kidney effects and developmental toxicity in laboratory animals.
  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 8050

Date of notice confirming acceptance: December 23, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient “substituted olefin copolymer” in the controlled product, together with its percent concentration, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that medical attention should be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for skin contact, add a statement to the effect that skin should be flushed continuously with water for 20 minutes.
  4. Add oxides of carbon and nitrogen to the list of hazardous decomposition products.
  5. Disclose an LD50 (oral, female rat) value of 2.53 mL/kg and an LD50 (dermal, rabbit) value of 1.78 mL/kg for the confidential hazardous ingredient “alkoxylated long-chain alkyl alcohol”.
  6. Disclose that an ingredient in the controlled product has been shown to be irritating to the skin.

Registry Number 8051

Date of notice confirming acceptance: December 15, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of two additional hazardous ingredients “polyolefin amine alkenamine” and “polyether polyol” in the controlled product, together with their percent concentration, in an acceptable manner and indicate that these ingredients are considered hazardous under WHMIS criteria.
  2. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 8059

Date of notice confirming acceptance: September 7, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8067

Date of notice confirming acceptance: December 20, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add ingestion as an additional route of entry.
  2. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 8068

Date of notice confirming acceptance: December 20, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration range for the ingredient “other ester adducts” in an acceptable manner and indicate that the CAS registry number is not available.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention should be obtained immediately.

Registry Number 8069

Date of notice confirming acceptance: December 20, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Number 8076

Date of notice confirming acceptance: October 31, 2011

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an AIHA WEEL–TWA Exposure Limit of 10 ppm, 8 hours, for the ingredient “N-methyl pyrrolidone”.
  2. Disclose an LD50 (oral, dermal, rabbit) value of 8 g/kg for the hazardous ingredient “N-methyl pyrrolidone” and a value of 1 210 mg/kg for the hazardous ingredient “dimethylethanolamine”.
  3. In relation to the first aid information shown on the MSDS for skin contact, add a statement to the effect that skin should be flushed continuously with lukewarm, gently flowing water for at least 30 minutes and obtain medical attention immediately.
  4. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water to drink.
  6. In relation to the first aid information shown on the MSDS for ingestion, add a statement that if vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
  7. Disclose that repeated inhalation of “N-methyl-pyrrolidone” has been shown to cause central nervous system (CNS) depression, atrophy and necrosis of the thymus gland, spleen, lymph nodes and bone marrow hypoplasia while repeated ingestion has been shown to cause kidney effects.
  8. Disclose that the ingredient “dimethylethanolamine” in the controlled product has been shown to cause skin corrosion in animals.
  9. Disclose that the hazardous ingredient “N-methyl-pyrrolidone” in the controlled product has been shown to cause fetotoxic effects in laboratory animals, in the absence of maternal toxicity.
  10. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1B and E.

Registry Number 8077

Date of notice confirming acceptance: January 3, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8078

Date of notice confirming acceptance: November 29, 2011

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of the ingredient “siloxane polyalkyleneoxide copolymer” in the controlled product, together with its percent concentration.

Registry Numbers 8086 and 8087

Date of notice confirming acceptance: November 21, 2011

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of the hazardous ingredient “polyether amine” in the controlled product, together with its CAS Registry Number 220795-29-9 and percent concentration of 47%.
  2. Disclose an LD50 (oral, rat) value of 8 400 mg/kg for the ingredient “solvent naphtha (petroleum), light aromatic”.

Registry Number 8099

Date of notice confirming acceptance: January 4, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8109

Date of notice confirming acceptance: December 16, 2011

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of two additional confidential hazardous ingredients “poly(oxyalkylene)alkaryl ether” and “alkyl benzene” in the controlled product and their concentrations in an acceptable manner.
  2. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 8120

Date of notice confirming acceptance: February 16, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of two additional confidential hazardous ingredients “mixture of phosphoglycerides” and “fatty acids, tall oil, reaction product with polyalkeneamines” in the controlled product and their concentrations in an acceptable manner.
  2. Disclose the percent concentration for the ingredients “inorganic acid”, “isoalkyl ester” and “potassium salt” in the controlled product.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.
  4. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 8125

Date of notice confirming acceptance: December 8, 2011

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink.
  2. Add oxides of nitrogen to the list of hazardous combustion products.

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17.1(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

CLAIMS WHERE THE SCREENING OFFICER ORDERED THE
CLAIMANT TO COMPLY WITH THE APPLICABLE
DISCLOSURE REQUIREMENTS

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of any information that the screening officer ordered to be disclosed on a material safety data sheet reviewed by the screening officer.

Registry Number 7734

Date of order: September 26, 2011

The claimant had been ordered to amend certain aspects of the content of the MSDS. The claimant had been further ordered to amend the MSDS as indicated below.

  1. Disclose that the controlled product can be corrosive to the eyes and skin.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped. Either remove the statement with respect to ethanol therapy or add “only under the supervision of a physician”.
  3. Disclose the provincial exposure values for “ethylene glycol” of (BC, C) 100 mg/m3, (BC, C) 50 ppm, (QC, VECD/Plafond) 50 ppm, and (QC, VECD/Plafond) 127 mg/m3 and also for “sodium hydroxide” of (BC, C) 2 mg/m3 and (QC, VECD/Plafond) 2 mg/m3.
  4. If the WHMIS classifications or pictograms are shown on the MSDS, disclose that the controlled product is also in classes D1B and E.

Registry Number 7769

Date of order: January 23, 2012

The claimant had been ordered to amend certain aspects of the content of the MSDS. The claimant had been further ordered to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.
  2. Disclose an ACGIH TLV–TWA Exposure Limit of 2 mg/m3 and an ACGIH TLV–STEL value of 6 mg/m3 for the hazardous ingredient “inorganic acid”.
  3. Add oxides of sulfur to the list of hazardous combustion products.

Registry Number 7832

Date of order: September 26, 2011

The claimant had been ordered to amend certain aspects of the content and format of the MSDS. The claimant had been further ordered to amend the MSDS as indicated below.

  1. Disclose that ingredients in the controlled product can be corrosive to the eyes and skin.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with water for 60 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, add a statement that if vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
  4. If the WHMIS classifications or pictograms are shown on the MSDS, disclose that the controlled product is also in classes D1B and E and disclose pictograms for D1 (skull and crossbones) and E.

Registry Number 7833

Date of order: September 26, 2011

The claimant had been ordered to amend certain aspects of the content and format of the MSDS. The claimant had been further ordered to amend the MSDS as indicated below.

  1. Disclose that ingredients in the controlled product can be corrosive to the eyes and skin.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with water for 60 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement with respect to the administration of hard liquor in the event of ingestion of a controlled product.
  4. Disclose that exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals in the absence of maternal toxicity.
  5. If the WHMIS classifications or pictograms are shown on the MSDS, disclose that the controlled product is also in class E.

Registry Number 7868

Date of order: October 13, 2011

Disclose the chemical identity and CAS registry number for the hazardous ingredient “aromatic methanamine” (CAS Registry Number 94270-86-7).

Registry Number 7869

Date of order: October 13, 2011

The claimant has been ordered to amend the MSDS as indicated below.

  1. Disclose the chemical identity and CAS registry numbers for the hazardous ingredients “(tetrapropenyl)-butanedioic acid” (CAS Registry Number 27859-58-1), “N-phenylbenzenamine, reaction products with 2,4,4-trimethylpentene” (CAS Registry Number 68411-46-1) and “(tetrapropenyl)-butanedioic acid, monoester with 1,2-propanediol” (CAS Registry Number 52305-09-6).

Registry Number 7953

Date of order: November 29, 2011

The claimant has been ordered to amend the MSDS as indicated below.

  1. Disclose the CAS Registry Number 32612-48-9 for the ingredient “ammonium lauryl ether sulphate”.

Registry Number 7964

Date of order: December 13, 2011

The claimant had been ordered to amend certain aspects of the content and wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 7988

Date of order: December 9, 2011

The claimant had been ordered to amend certain aspects of the content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Pursuant to paragraphs 18(1)(a) and 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS or label.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Pursuant to subsection 24(3) of the Controlled Products Regulations, amended labels must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. It also affords the opportunity to an affected party to appeal an undertaking. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part Ⅰ, to the Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-998-2363 (telephone).

GERHARD BRUINS
Acting Director, Screening Division

[23-1-o]

PUBLIC SERVICE COMMISSION

PUBLIC SERVICE EMPLOYMENT ACT

Permission granted

The Public Service Commission of Canada, pursuant to section 116 of the Public Service Employment Act, hereby gives notice that it has granted permission, pursuant to subsection 115(2) of the said Act, to Sharon Lutz, Multifunctional Administrative Assistant (CR-4), Department of National Defence, Kentville, Nova Scotia, to be a candidate, before and during the election period, for the position of Councillor for the Municipality of the County of Kings, Nova Scotia, in a municipal election to be held on October 20, 2012.

May 28, 2012

KATHY NAKAMURA
Director General
Political Activities and
Non-Partisanship Directorate

[23-1-o]